These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 8529997

  • 1. Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high-density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency.
    Akita H, Chiba H, Tsuji M, Hui SP, Takahashi Y, Matsuno K, Kobayashi K.
    Hum Genet; 1995 Nov; 96(5):521-6. PubMed ID: 8529997
    [Abstract] [Full Text] [Related]

  • 2. A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms.
    Le Goff W, Guerin M, Nicaud V, Dachet C, Luc G, Arveiler D, Ruidavets JB, Evans A, Kee F, Morrison C, Chapman MJ, Thillet J.
    Atherosclerosis; 2002 Apr; 161(2):269-79. PubMed ID: 11888509
    [Abstract] [Full Text] [Related]

  • 3. Significance of a polymorphism (G-->A transition) in the -75 position of the apolipoprotein A-I gene promoter on serum high density lipoprotein-cholesterol levels in Japanese hyperlipidemic subjects.
    Tashiro J, Morisaki N, Kobayashi J, Bujo H, Kanzaki T, Murano S, Saito Y.
    J Atheroscler Thromb; 2001 Apr; 8(3):95-100. PubMed ID: 11866037
    [Abstract] [Full Text] [Related]

  • 4. Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism.
    Lu H, Inazu A, Moriyama Y, Higashikata T, Kawashiri MA, Yu W, Huang Z, Okamura T, Mabuchi H.
    J Mol Med (Berl); 2003 Apr; 81(4):246-55. PubMed ID: 12700892
    [Abstract] [Full Text] [Related]

  • 5. The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.
    Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Bakker SJ, van der Steege G, van Tol A, Dullaart RP, PREVEND Study Group.
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4198-204. PubMed ID: 15840744
    [Abstract] [Full Text] [Related]

  • 6. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.
    Inazu A, Jiang XC, Haraki T, Yagi K, Kamon N, Koizumi J, Mabuchi H, Takeda R, Takata K, Moriyama Y.
    J Clin Invest; 1994 Nov; 94(5):1872-82. PubMed ID: 7962532
    [Abstract] [Full Text] [Related]

  • 7. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.
    Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhama Y, Mabuchi H, Tall AR.
    N Engl J Med; 1990 Nov 01; 323(18):1234-8. PubMed ID: 2215607
    [Abstract] [Full Text] [Related]

  • 8. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.
    Dullaart RP, Hoogenberg K, Riemens SC, Groener JE, van Tol A, Sluiter WJ, Stulp BK.
    Diabetes; 1997 Dec 01; 46(12):2082-7. PubMed ID: 9392500
    [Abstract] [Full Text] [Related]

  • 9. Role of genetic factors (CETP gene Taq I B polymorphism and Apo A-I gene Msp I polymorphism) in serum HDL-C levels in women.
    Motohashi Y, Maruyama T, Murata M, Nakano S, Maruyama C, Kyotani S, Tsushima M, Saruta T.
    Nutr Metab Cardiovasc Dis; 2004 Feb 01; 14(1):6-14. PubMed ID: 15053158
    [Abstract] [Full Text] [Related]

  • 10. Rapid detection and prevalence of cholesteryl ester transfer protein deficiency caused by an intron 14 splicing defect in hyperalphalipoproteinemia.
    Inazu A, Koizumi J, Haraki T, Yagi K, Wakasugi T, Takegoshi T, Mabuchi H, Takeda R.
    Hum Genet; 1993 Mar 01; 91(1):13-6. PubMed ID: 8454281
    [Abstract] [Full Text] [Related]

  • 11. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency.
    Moriyama Y, Okamura T, Inazu A, Doi M, Iso H, Mouri Y, Ishikawa Y, Suzuki H, Iida M, Koizumi J, Mabuchi H, Komachi Y.
    Prev Med; 1998 Mar 01; 27(5 Pt 1):659-67. PubMed ID: 9808796
    [Abstract] [Full Text] [Related]

  • 12. Polymorphisms of the gene coding for the cholesteryl ester transfer protein and plasma lipid levels in Italian and Greek migrants to Australia.
    Mitchell RJ, Earl L, Williams J, Bisucci T, Gasiamis H.
    Hum Biol; 1994 Feb 01; 66(1):13-25. PubMed ID: 7908890
    [Abstract] [Full Text] [Related]

  • 13. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.
    Yamashita S, Hirano K, Sakai N, Matsuzawa Y.
    Biochim Biophys Acta; 2000 Dec 15; 1529(1-3):257-75. PubMed ID: 11111094
    [Abstract] [Full Text] [Related]

  • 14. New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation.
    Dachet C, Poirier O, Cambien F, Chapman J, Rouis M.
    Arterioscler Thromb Vasc Biol; 2000 Feb 15; 20(2):507-15. PubMed ID: 10669650
    [Abstract] [Full Text] [Related]

  • 15. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.
    Hayek T, Chajek-Shaul T, Walsh A, Agellon LB, Moulin P, Tall AR, Breslow JL.
    J Clin Invest; 1992 Aug 15; 90(2):505-10. PubMed ID: 1644921
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.
    Do HQ, Nazih H, Luc G, Arveiler D, Ferrières J, Evans A, Amouyel P, Cambien F, Ducimetière P, Bard JM.
    Metabolism; 2009 Mar 15; 58(3):283-9. PubMed ID: 19217440
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.